12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-30), Haemonetics's 12-1 Month Momentum % is 1.96%.
The industry rank for Haemonetics's 12-1 Month Momentum % or its related term are showing as below:
HAE's 12-1 Month Momentum % is ranked better than 68.9% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: -17.225
vs HAE: 1.96
Competitive Comparison of Haemonetics's 12-1 Month Momentum %
For the Medical Instruments & Supplies subindustry, Haemonetics's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haemonetics's 12-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Haemonetics's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Haemonetics's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Haemonetics 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Haemonetics's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HAE has been successfully added to your